Schrödinger, Inc. ($SDGR)
Filing Information
| Accession Number | 0001797672-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
108,609
Total Value
$26,454.35
P&L
+inf% (+$1,298,116.60)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | — | Mar 2, 2026 | Grant/Award | 24,250 | $0.00 | $0.00 | 39,875 | Direct | — | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | — | Mar 2, 2026 | Grant/Award | 6,077 | $0.00 | $0.00 | 45,952 | Direct | — | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | — | Mar 2, 2026 | Grant/Award | 27,576 | $0.00 | $0.00 | 73,528 | Direct | — | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Common Stock | — | Mar 2, 2026 | Sale | 2,206 | $11.99 | $26,454.35 | 71,322 | Direct | — | View Details | |
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Stock Option (right to buy) | Derivative | Mar 2, 2026 | Grant/Award | 48,500 | $0.00 | $0.00 | 48,500 | Direct | — | View Details |